Recombinant Human PD-L1/B7-H1/CD274(Fc fusion)
- 发布日期: 2017-06-23
- 更新日期: 2026-01-28
产品详请
| 产地 |
北京
|
| 品牌 |
solarbio
|
| 货号 |
P00219
|
| 保存条件 |
Lyophilized protein should be stored at < -20癈, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7癈 for 2-7 days. Aliquots of reconstituted samples are stable at < -20癈 for 3 months.
|
| 保质期 |
3个月个月
|
简介:Recombinant Human Programmed Cell Death 1 Ligand 1 is produced by our Mammalian expression system and the target gene encoding Phe19-Thr239 is expressed with a Fc tag at the C-terminus.
种属:Human
表达系统:Human cells
Endotoxin:Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test.
storage:Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks.
Reconstituted protein solution can be stored at 4-7°C for 2-7 days.
Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Background:CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.